RBLCM
PFE icon

Roaring Blue Lion Capital Management’s Pfizer PFE Stock Holding History

Roaring Blue Lion Capital Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-126,691
Closed -$3.37M – 59
2013
Q2 		$3.37M Buy
+126,691
New +$3.5M 1.74% 29

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Roaring Blue Lion Capital Management's PFE Position: Q3 2013 in Review

Roaring Blue Lion Capital Management sold out of Pfizer (PFE) in Q3 2013, closing a stake of 126,691 shares — an estimated $3.37M sold.

Roaring Blue Lion Capital Management first reported a position in PFE in Q2 2013 and held it in 1 quarter. The position peaked at $3.37M in Q2 2013. 1,606 funds tracked by Wall St. Rank hold PFE as of Q3 2013.

  • Roaring Blue Lion Capital Management reported no remaining Pfizer position as of Q3 2013 after selling out during the quarter.
  • Roaring Blue Lion Capital Management sold 126,691 Pfizer shares in Q3 2013, an estimated $3.37M.
  • Roaring Blue Lion Capital Management first reported a position in Pfizer in Q2 2013 and held it in 1 quarter.
  • Roaring Blue Lion Capital Management's Pfizer position peaked at $3.37M in Q2 2013.
  • 1,606 funds tracked by Wall St. Rank held Pfizer as of Q3 2013.

Based on Roaring Blue Lion Capital Management's 13F filing for Q3 2013, filed 30 Oct 2013.